Doctor Elisabetta Salvioni
Monzino Cardiology Centre, Milan (Italy)
Member of:
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
A real-world population with HFrEF treated with dapagliflozin or empagliflozin: a comparative analysis with DAPA-HF and EMPEROR REDUCED studies
Event: Heart Failure 2024
Topic: Treatment
Session: ePosters in chronic heart failure - treatment 2
Beta-blockers effects according to sex: does selectivity and dose equally matter?
Event: ESC Congress 2023
Topic: Pharmacotherapy
Session: Pharmacotherapy in heart failure
Prognostic evaluation of heart failure in women: insight from the MECKI score database
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Nuggets from international and large registries
How to calculate the anaerobic threshold to stratify HF prognosis: a comparison between absolute value, percentage of peakVO2 or percentage of predicted maxVO2 ina large multicenter cohort of HFrEF
Event: Heart Failure 2022
Topic: Epidemiology, Prognosis, Outcome
Session: Modern technologies in heart failure
'You can leave your mask on': effects on cardiopulmonary parameters of different airway protection masks
Event: Heart Failure 2021
Topic: Exercise Testing
Session: ePoster session
